Bentyl Uses: IBS, Off-Label Pain, and Side Effects

Bentyl is a brand name for dicyclomine hydrochloride, an antispasmodic drug prescribed primarily to relieve the cramping, pain, and altered bowel habits of irritable bowel syndrome (IBS). It has been on the market since the 1950s and remains one of the most commonly prescribed gut-specific antispasmodics in North America, though its evidence base is thinner than many patients and prescribers assume. Beyond IBS, dicyclomine shows up in a handful of off-label roles that are worth understanding, along with safety concerns that matter for specific groups of people.

How Bentyl Works

Dicyclomine belongs to a class of drugs called anticholinergics, which block a chemical messenger called acetylcholine from activating certain receptors in smooth muscle. The smooth muscle lining your intestinal wall contracts in response to acetylcholine, and in IBS those contractions can become painful, excessive, or poorly coordinated. By blocking that signal, dicyclomine relaxes the gut wall and reduces spasm. It also has a modest direct relaxant effect on smooth muscle itself, independent of the nerve-blocking action, which sets it apart from “pure” anticholinergics like atropine.

Because the drug is not perfectly selective for the gut, it also affects acetylcholine receptors elsewhere in the body. That is why you can experience dry mouth, blurred vision, drowsiness, and urinary hesitancy while taking it. Those side effects are not a flaw in a particular batch or a sign of an allergy; they are the predictable result of blocking the same receptor in your salivary glands, eyes, brain, and bladder.

IBS and the Evidence Behind the Primary Use

The FDA-approved indication for Bentyl is “functional bowel/irritable bowel syndrome.” The best-known trial, published in the Journal of Clinical Gastroenterology, found that dicyclomine at 40 mg four times daily was superior to placebo over a two-week period for overall patient improvement, abdominal pain, abdominal tenderness, and bowel habit regulation.¹ A review of the North American evidence confirmed that two randomized, placebo-controlled studies showed dicyclomine improving IBS symptoms relative to placebo, though both trials were short, lasting only ten days to two weeks.²

That brevity matters. IBS is a chronic, fluctuating condition, and two weeks of data leaves open the question of whether the drug holds up over months. In practice, many gastroenterologists prescribe dicyclomine on an as-needed basis rather than as a continuous daily medication, partly because the short trial durations make the case for long-term use less convincing, and partly because the anticholinergic side effects tend to become more bothersome over time.

A broader meta-analysis pooling data from over 2,500 patients across multiple antispasmodics (including dicyclomine) found that the class as a whole improved global IBS symptoms with an odds ratio of about 1.55, meaning roughly one-and-a-half times the odds of improvement compared to placebo.³ Pain specifically improved too, with a similar odds ratio of about 1.52. These are real but modest effects. Antispasmodics help, but they are not transformative for most people.

How Bentyl Stacks Up Against Other Antispasmodics

Patients often wonder whether dicyclomine is the best option in its class or whether another antispasmodic would work better. A systematic review and meta-analysis published in the BMJ looked at multiple antispasmodic agents head to head (as much as the trial data allowed). In a single trial contributing to that review, dicyclomine showed a relative risk of persistent symptoms of 0.65 compared to placebo, meaning patients on the drug were about 35 percent less likely to still have symptoms at the end of the study.⁴ Other agents in the same review, like mebeverine and alverine, showed weaker or non-significant effects in the single trials available for each.

The catch is that the comparison is lopsided. Agents like otilonium bromide and hyoscine butylbromide have been studied in more and larger trials, particularly outside North America. In the meta-analysis of Latin American and European data, otilonium and the alverine-plus-simethicone combination reached statistical significance for global improvement, while dicyclomine was pooled into the class-wide estimate rather than singled out.⁵ So the honest picture is that dicyclomine is one of several antispasmodics with modest evidence of benefit, and which one gets prescribed often depends more on what is available in your country and what your doctor is familiar with than on clear superiority data.

Dosing in Practice

Bentyl comes in 10 mg and 20 mg capsules, an oral syrup (10 mg per 5 mL), and an injectable form (10 mg/mL). The usual starting dose for adults is 20 mg four times a day, though many doctors begin at 10 mg to see how a patient tolerates the anticholinergic effects. The maximum recommended dose is 40 mg four times daily (160 mg per day). One of the two pivotal IBS trials used that top dose continuously, and the review noted that adverse events occurred in about 69 percent of patients at 160 mg per day compared to just 16 percent on placebo.⁶ That is a steep side-effect rate, which is why many clinicians prefer to keep the dose lower and use the drug as needed before meals or before situations that tend to trigger symptoms, rather than round the clock.

The injectable form is used less often and is typically reserved for situations where oral dosing is not feasible. It is given intramuscularly, not intravenously, because IV injection can cause thrombosis and injection-site reactions.

Off-Label Uses

Dicyclomine’s smooth-muscle-relaxing properties make it potentially useful anywhere painful spasm is the problem, not just in the colon. Two off-label applications show up in the clinical literature.

Menstrual Cramps

In parts of South Asia, dicyclomine is widely self-medicated for period pain. A survey-based study of women with primary dysmenorrhea found that dicyclomine was the single most common self-medicated drug, used by about 35 percent of respondents, ahead of mefenamic acid and combination products.⁷ This makes pharmacological sense: the uterus is a smooth-muscle organ, and cramp pain is caused by exaggerated contractions. Dicyclomine reduces those contractions by the same mechanism it uses in the gut. It is not a first-line recommendation in most Western guidelines for period pain (NSAIDs like ibuprofen usually are), but the widespread real-world use suggests it provides meaningful relief for many women.

Kidney Stone Pain

Renal colic, the severe flank pain caused by a kidney stone passing through the ureter, involves spasm of the ureteral smooth muscle around the stone. A clinical study found that a fixed-dose combination of dexketoprofen (a painkiller) and dicyclomine showed superior efficacy and tolerability compared to a combination of diclofenac and dicyclomine in patients with acute renal colic.⁸ In both arms of that study, dicyclomine was part of the treatment. The logic is straightforward: relax the spasming ureter and the pain eases. This use is more common in clinical settings in India and parts of the Middle East than in North America or Europe, where other antispasmodics or alpha-blockers tend to be preferred for ureteral colic.

Side Effects and What to Watch For

Because dicyclomine blocks acetylcholine broadly, its side-effect profile is largely predictable. The most common complaints are dry mouth, dizziness, blurred vision, drowsiness, and constipation. Less common but more disruptive effects include urinary retention, confusion, and rapid heartbeat. As mentioned earlier, at the highest approved dose these effects are common enough to affect roughly two-thirds of patients.

A few practical notes on managing them:

Dry mouth: Sipping water, chewing sugar-free gum, or using saliva substitutes can help. Dry mouth is not dangerous in itself but can contribute to dental problems if the drug is used long term.
Drowsiness: Taking the dose after meals and avoiding alcohol can reduce the sedation. Do not drive or operate heavy equipment until you know how the drug affects you.
Constipation: This is ironic for a drug prescribed for a condition that often involves constipation-predominant IBS (IBS-C). If your IBS pattern leans toward constipation rather than diarrhea, dicyclomine can make things worse. It is generally better suited to diarrhea-predominant or mixed-pattern IBS.
Heat intolerance: Anticholinergics reduce sweating, which impairs your ability to cool down. In hot weather or during vigorous exercise, overheating becomes a real risk, especially in older adults.

Who Should Not Take Bentyl

Several groups face elevated risk from dicyclomine. The most important are infants, pregnant individuals, and older adults with cognitive concerns.

Infants

Dicyclomine was once used to treat infant colic, and the consequences were alarming. Reports documented serious and sometimes life-threatening reactions in babies under six months, including breathing difficulties, seizures, fainting, dangerous swings in heart rate, and severe muscle weakness. These reactions occurred at recommended doses, not overdoses, and typically appeared within minutes to hours of administration.⁹ The drug is now contraindicated in infants under six months and is generally avoided in all children under six months of age. Older children sometimes receive it for specific indications, but always with caution.

Pregnancy

The American Gastroenterological Association’s position statement on gastrointestinal medications in pregnancy categorized dicyclomine as a drug to avoid, citing possible congenital anomalies and limited human data with potential toxicity.¹⁰ The data are sparse rather than conclusive, which means the drug has not been proven harmful in a large study, but there is also not enough reassuring human evidence to call it safe. For pregnant women with IBS symptoms, dietary modification, fiber supplementation, and certain better-studied medications are preferred.

Older Adults and Anticholinergic Burden

Every anticholinergic drug adds to a person’s total “anticholinergic burden,” and older adults are especially sensitive because the brain’s acetylcholine system is already declining with age. The concern is both short-term (confusion, falls, urinary retention) and long-term (a possible link to dementia with chronic anticholinergic exposure). Research using stem-cell-based models alongside pharmacoepidemiological data found that antispasmodics like dicyclomine did not show overt cytotoxicity to neurons at tested concentrations, unlike some antidepressants and bladder anticholinergics that did.¹¹ That is somewhat reassuring, but a cell-culture study is a long way from proving safety in real-world long-term use. The Beers Criteria, a widely used list of medications to avoid or use cautiously in older adults, includes anticholinergics like dicyclomine because of the acute cognitive and fall risks regardless of the dementia question. In practice, if you are over 65, your doctor will likely start with the lowest possible dose and limit the duration.

Can Bentyl Be Abused?

Anticholinergics are not typically thought of as drugs of abuse, but dicyclomine can produce euphoria, altered perception, and mild hallucinatory effects at high doses, driven by its central anticholinergic activity. A published case report described an 18-year-old woman who abused dicyclomine for a year and a half, resulting in overt anticholinergic toxicity.¹² The report was explicitly framed as extremely rare. Unlike opioids or benzodiazepines, dicyclomine is not a controlled substance and is not subject to prescription-monitoring programs in most jurisdictions. The risk is low but not zero, and clinicians should keep it in mind when a patient requests frequent refills at escalating doses without a clear clinical reason.

Why the Evidence Base Remains Thin

Given how widely Bentyl is prescribed, it is striking how limited the clinical trial evidence really is. The two randomized controlled trials that form the backbone of its FDA-approved use enrolled relatively small numbers of patients and lasted no longer than two weeks.¹³ By modern standards, a drug seeking approval for a chronic condition would need larger, longer trials with more rigorous endpoints. Dicyclomine got its approval in an era with lower evidentiary bars, and because it is now generic and inexpensive, no manufacturer has a financial incentive to fund the large-scale trials that would either solidify or undermine its place in treatment.

This does not mean the drug does not work. Millions of patients and decades of clinical experience suggest it provides real short-term relief for many people with IBS-related cramping. But it does mean that questions about long-term efficacy, optimal dosing strategies, which IBS subtypes respond best, and how dicyclomine compares head to head against newer agents remain largely unanswered. If your doctor prescribes it and it helps your symptoms without intolerable side effects, the drug is doing its job. If it does not help within a couple of weeks, there is little reason from the evidence to keep pushing the dose upward and waiting longer.

Availability and Formulations Around the World

In the United States, Bentyl is the most recognized brand name, though generic dicyclomine is widely available and significantly cheaper. In India, dicyclomine is sold under dozens of brand names, often in fixed-dose combinations with painkillers like mefenamic acid or paracetamol, marketed for menstrual cramps, abdominal colic, and renal stone pain. These combination products reflect the off-label uses described above and are available over the counter in many Indian pharmacies, which explains why self-medication rates are so high.

In the United Kingdom and much of Europe, dicyclomine is less commonly prescribed. Hyoscine butylbromide (sold as Buscopan) and mebeverine tend to dominate the antispasmodic market there. The choice is not driven by superior evidence for one drug over another but by historical prescribing patterns, regulatory approvals, and what happens to be available in each country’s pharmacy formulary. If you move between countries and need to continue antispasmodic therapy, the active ingredient name (dicyclomine or dicycloverine, depending on the naming convention) is more useful than the brand name when talking to a new doctor or pharmacist.